Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Form 8.3 - Servelec Group plc

24 Nov 2017 10:37

RNS Number : 4678X
Oryx International Growth Fund Ld
24 November 2017
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Oryx International Growth Fund Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Harwood Capital LLP

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Servelec Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

No

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

23 November 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

ORD GBP 0.5

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

900,000

1.29

(2) Cash-settled derivatives:

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

TOTAL:

900,000

1.29

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

24 November 2017

Contact name:

Sarah Hendry

BNP Paribas Securities Services S.C.A., Guernsey Branch as Company Secretary

Telephone number:

01481 750822

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETEAEFLADKXFFF
Date   Source Headline
3rd Aug 20169:15 amRNSNet Asset Value(s)
28th Jul 20165:05 pmRNSNotification of Major Interest in Shares
28th Jul 20163:33 pmRNSHolding(s) in Company
26th Jul 20169:45 amRNSHolding(s) in Company
15th Jul 20167:32 amRNSHolding(s) in Company
13th Jul 20167:00 amRNSAnnual Report and Accounts and Notice of AGM
5th Jul 20161:14 pmRNSHolding(s) in Company
4th Jul 20165:01 pmRNSAnnual Financial Report
4th Jul 20168:18 amRNSHolding(s) in Company
24th Jun 201610:14 amRNSNet Asset Value(s)
3rd Jun 20161:36 pmRNSHolding(s) in Company
27th May 20163:08 pmRNSNet Asset Value(s)
10th May 20165:30 pmRNSTransaction in Own Shares
10th May 20165:30 pmRNSTransactions in a Close Period
28th Apr 201612:22 pmRNSNet Asset Value(s)
29th Mar 20169:37 amRNSNet Asset Value(s)
23rd Feb 20163:36 pmRNSNet Asset Value(s)
18th Feb 201611:07 amRNSForm 8.3 - Tangent Communications plc
28th Jan 20167:00 amRNSDisclosure of Home Member State
25th Jan 201612:19 pmRNSNet Asset Value(s)
18th Jan 201612:41 pmRNSHolding(s) in Company
18th Jan 201611:56 amRNSHolding(s) in Company
15th Jan 20163:11 pmRNSHolding(s) in Company
13th Jan 20169:17 amRNSHolding(s) in Company
18th Dec 20158:02 amRNSNet Asset Value(s)
10th Dec 20157:00 amRNSTR-1: Notification Of Major Interest In Shares
4th Dec 201511:00 amRNSTR-1: Notification of major interest in shares
3rd Dec 201512:28 pmRNSHolding(s) in Company
27th Nov 20153:44 pmRNSHolding(s) in Company - Replacement
24th Nov 20153:17 pmRNSHolding(s) in Company
24th Nov 201510:49 amRNSNet Asset Value(s)
20th Nov 20157:00 amRNSHalf Yearly Report
16th Nov 20156:00 pmRNSPortfolio Update
14th Oct 201512:07 pmRNSNet Asset Value(s)
1st Oct 201511:51 amRNSHolding(s) in Company Replacement
30th Sep 20156:08 pmRNSHolding(s) in Company
21st Sep 201510:38 amRNSNet Asset Value(s)
18th Sep 20154:37 pmRNSHolding(s) in Company
1st Sep 20156:00 pmRNSTransaction in Own Shares
1st Sep 20155:21 pmRNSHolding(s) in Company
27th Aug 201512:48 pmRNSNet Asset Value(s)
25th Aug 20152:15 pmRNSForm 8.3 - EKF Diagnostics Holdings Plc
25th Aug 20151:10 pmRNSHolding(s) in Company
17th Aug 20157:00 amRNSResult of AGM
13th Aug 20153:20 pmRNSHolding(s) in Company
7th Aug 20153:48 pmRNSHolding(s) in Company
7th Aug 20157:00 amRNSHolding(s) in Company
28th Jul 201511:31 amRNSHolding(s) in Company
23rd Jul 20159:41 amRNSNet Asset Value(s)
20th Jul 20155:30 pmRNSAnnual Report and Accounts and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.